ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 663

$712K Total Retail Price of All Prescriptions

Rank: 27 out of 663

411 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 411 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 411 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,170 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 482 359 1 3
LISINOPRIL 344 224 2 2
AMLODIPINE BESYLATE 311 226 3 5
FUROSEMIDE 246 207 4 7
SIMVASTATIN 228 182 5 1
HYDROCODONE-ACETAMINOPHEN 219 139 S3 6 6
OXYCODONE-ACETAMINOPHEN 199 130 S2 7 26
METFORMIN HCL 179 117 8 9
WARFARIN SODIUM 178 163 9 8
ZOLPIDEM TARTRATE 171 118 10 16
AZITHROMYCIN 159 112 11 64
TRAZODONE HCL 136 106 12 34
HYDROCHLOROTHIAZIDE 132 81 13 12
METOPROLOL TARTRATE 125 104 14 11
GABAPENTIN 121 90 15 20
SPIRIVA 120 100 16 62
ATORVASTATIN CALCIUM 115 84 17 13
CITALOPRAM HBR 112 76 18 18
PANTOPRAZOLE SODIUM 104 66 19 45
ESCITALOPRAM OXALATE 98 57 20 77
CARISOPRODOL 95 31 R 21 134
ADVAIR DISKUS 94 68 22 53
NEXIUM 93 80 23 43
OXYCODONE HCL 93 56 S2 23 41
METOPROLOL SUCCINATE 89 70 25 25
OMEPRAZOLE 88 65 26 4
TAMSULOSIN HCL 87 75 27 24
TRAMADOL HCL 85 63 28 17
LEVEMIR FLEXPEN 78 41 29 276
VOLTAREN 75 48 30 107
LYRICA 75 47 30 96
CELEBREX 74 63 32 85
RANITIDINE HCL 71 58 33 31
PROAIR HFA 69 53 34 33
POTASSIUM CHLORIDE 69 46 34 23
LIDODERM 67 50 36 67
ATENOLOL 62 35 37 10
ALENDRONATE SODIUM 61 61 38 15
JANUMET 60 39 39 147
OXYCODONE HCL-ACETAMINOPHEN 59 18 S2 40 128
DONEPEZIL HCL 57 43 41 40
CLONIDINE HCL 55 40 42 79
LANTUS 55 51 42 48
MIRTAZAPINE 54 53 44 52
LEVOFLOXACIN 52 42 45 92
FENTANYL 51 38 S2 46 75
ALLOPURINOL 51 23 46 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.